Drugs | % Apoptosis | |||
---|---|---|---|---|
Untreated | ZB4 | Fas-L | Fas-L + ZB4 | |
Control | 15.6 ± 0.1 | 12.7 ± 0.5 | 20 ± 2.4 | 13.9 ± 1.8 |
DXR | 51.1 ± 7.6 | 54.2 ± 7.8 | 84.9 ± 4.72-150 | 60.5 ± 4.1 |
MEN 10755 | 37.5 ± 4.3 | 41.6 ± 4.6 | 72.8 ± 10.92-150 | 39.3 ± 5.9 |
Cells were treated with 0.1 μM MEN 10755 or DXR for 24 h, then stimulated for 3 h with Fas-L alone (100 ng/ml) or in combination with the anti-Fas ZB4 antibody (2 μg/ml). Values are the mean of three independent experiments and Fas-L effects with and without ZB4 were statistically compared versus untreated, DXR- or MEN 10755-treated cells.
↵2-150 p < 0.05.